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Abstract
Background Biologic grafts are increasingly used instead of synthetic mesh for parastomal hernia repair due to concerns of
synthetic mesh-related complications. This systematic review was designed to evaluate the use of these collagen-based
scaffolds for the repair of parastomal hernias.
Methods Studies were retrieved after searching the electronic databases MEDLINE, EMBASE and Cochrane CENTRAL.
The search terms ‘paracolostomy’, ‘paraileostomy’, ‘parastomal’, ‘colostomy’, ‘ileostomy’, ‘hernia’, ‘defect’, ‘closure’,
‘repair’ and ‘reconstruction’ were used. Selection of studies and assessment of methodological quality were performed with
a modified MINORS index. All reports on repair of parastomal hernias using a collagen-based biologic scaffold to reinforce
or bridge the defect were included. Outcomes were recurrence rate, mortality and morbidity.
Results Four retrospective studies with a combined enrolment of 57 patients were included. Recurrence occurred in 15.7%
(95% confidence interval [CI] 7.8–25.9) of patients and wound-related complications in 26.2% (95% CI 14.7–39.5). No
mortality or graft infections were reported.
Conclusions The use of reinforcing or bridging biologic grafts during parastomal hernia repair results in acceptable rates of
recurrence and complications. However, given the similar rates of recurrence and complications achieved using synthetic
mesh in this scenario, the evidence does not support use of biologic grafts.
Keywords Biologic graft . Allograft . Xenograft .
Parastomal hernia
Introduction
Parastomal herniation is a common complication following
creation of an ileostomy or colostomy, with observed rates of
up to 28% and 48%, respectively.1 Besides risk of incarcer-
ation and stenosis of the bowel, parastomal herniation can
cause pain, discomfort and an ill-fitting pouching system that
in turn may cause leakage and skin excoriation. Needless to
say, body image is adversely affected in patients that might
already be experiencing social problems associated with the
presence of a stoma.2 Surgical treatment modalities available
are relocation of the stoma and repair of the defect using
either direct suture repair, or bridging or reinforcement with
prostheses. Relocation of the stoma does not address tissue
weakness secondary to systemic risk factors and, just like
direct suture repair, often results in high recurrence rates.3,4
Since the introduction of synthetic mesh to reinforce or
bridge the defect, this procedure has been regarded as the
best possible care for parastomal herniation, showing lower
recurrence rates.1,5 Its prophylactic use at the time of initial
stoma creation is now often propagated to prevent future
herniation.5,6 At the same time, reservations have arisen with
respect to the implantation of synthetic mesh in close
proximity to bowel and stoma due to risk of erosion and
fistula formation.7 Also, dense adhesions may complicate
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future abdominal surgery.8 Besides these concerns, there is
the universal fear of infection when implanting foreign body
material, especially in contaminated fields.
Collagen-based biologic grafts have been produced since
the 1980s.9 These prostheses consist of an acellular collagen
matrix that is slowly degraded and replaced by fibro-
collagenous tissue of the host. Their properties depend on the
species and type of tissue that the material is extracted from,
the processing methods (including decellularisation and
sterilisation), and whether or not they are intentionally cross-
linked. Biologic grafts used for incisional hernia repair are
derived from either human dermis, porcine dermis, porcine
small intestinal submucosa, or bovine pericardium. During
processing, the materials are made functionally acellular to
prevent a foreign body response, while still maintaining their
extracellular collagenous structure that allows for the host
tissue ingrowth. Sterilisation of thematerials by ethylene oxide
gas or irradiation aims at making the final product pathogen
free. Some products receive additional cross-linking of the
collagen matrix to control or reduce the enzymatic degradation
of the graft. This should give the host more time to deposit
fibro-collagenous tissue and remodel the prosthesis into strong
native tissue. Due to their bio-compatibility resulting in rapid
vascularisation and migration of host (immune) cells, it is
thought that biologic prostheses are less prone to infection than
synthetic grafts. Moreover, they are soft and pliable which
potentially decreases the risk of discomfort and erosion into the
bowel. However, given the high financial costs of biologic
grafts, proper evidence of more beneficial outcomes or cost
savings in the long run are paramount to support their use. This
systematic review aims to evaluate the use of these acellular
collagen-based scaffolds for the repair of parastomal hernias,
focusing on recurrence and complication rates.
Methods
Search Methods for Study Identification
Studies were identified using the electronic databases
MEDLINE (including in-process and other non-indexed
citations, 1950–present), EMBASE (1980–present) and the
Cochrane Central Register of Controlled Trials. Search
terms used were: ‘parastomal’, ‘paracolostomy’, ‘para-
ileostomy’, ‘stoma’, ‘hernia’, ‘defect’ and ‘repair’. Terms
were searched for as free text and where applicable were
also mapped to MeSH terms. Full-text articles retrieved for
evaluation were scanned for other relevant references. No
limits were set on language or publication status. Titles and
abstracts were screened for eligibility and full-text articles
were retrieved. The last search was performed on 13
September 2010. All reports on repair of parastomal hernias
using a acellular collagen-based biologic scaffold as sole
material to reinforce or bridge the defect were included. All
other types of repair were excluded.
Assessment of Study Quality
All studies selected were subjected to a modified version of
the Methodological Index for Non-Randomised Studies
(MINORS) tool to evaluate their methodological quality
(Table 1). This instrument was constructed and validated
Item Criteria Option Score
1 A clearly stated aim Not reported 0
Partially reported, no clear aim 1
Clear aim 2
2 Minimum of 5 included patients No 0
Yes 2
3 Inclusion of consecutive patients Not reported 0
Patients in a certain time period 1
Consecutive patients+characteristics 2
4 Type of stoma specified Not reported 0
Reported 2
5 Surgical technique reported Not reported 0
Incomplete 1
Reported clearly, appropriate to aim 2
6 Report of end points Not reported 0
Recurrences only 1
Recurrences and postoperative complications 2
Maximum score: 12
Table 1 Modified Methodologi-
cal Index of Non-Randomised
Studies (MINORS)
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for appraisal of non-randomised trials in surgery.10 Studies
were scored independently by two authors (NJS, RPB).
This modified version contains six items with a maximum
score of two on each, yielding a maximum index of 12.
Studies with a total score less than nine, or no score on item
2, 5 or 6 were excluded from systematic review. Disagree-
ment was resolved by discussion and consensus between
authors. Also, the diagnostic modality for the primary
outcome was determined for every study.
Data Extraction
The primary outcome was the rate of parastomal hernia
recurrence observed, as defined by the respective authors.
Study characteristics (year of publication, no. of patients,
surgical technique, follow-up), perioperative (30 days) mor-
tality and rates and type of wound-related complications were
also noted. Total amount of wound-related complications
were calculated by adding up all relevant complications,
including only the studies with adequate reporting. Weighted
pooled proportions with their respective 95% confidence
intervals (CI) following the fixed-effects (inverse variance)
model were determined for recurrences and wound-related
complications using StatsDirect® statistical software.11
Results
A flowchart overview of the search is depicted in Fig. 1.
The search strategy yielded 333 titles and abstracts. After
screening, 317 records were excluded leaving 16 articles to
be retrieved and assessed for eligibility. Six of these were
excluded after assessment12–17 leaving a total of 10 articles
that reported on the repair of parastomal hernias with
biologic prostheses. After subjecting these to the modified
MINORS tool, another six were excluded due to too small
sample sizes18–22 and inadequate reporting on surgical
technique.23 This left four studies to be included in the
systematic review.24–27
Findings of Systematic Review
All included studies were retrospective with a combined
enrolment of 57 patients (range 11–20). The definition of a
recurrence was not given by any author. Follow-up ranged
from 8.1 to 50.2 months, and was done by clinical
examination in three25–27 and also by CT imaging in
one.26 One study was unclear as to how follow-up was
performed.24 No mortality was reported. Study character-
istics and outcomes including weighted pooled rates of
recurrence and wound-related complications are shown in
Table 2. The weighted pooled proportion of recurrences
was 15.7% (95% CI 7.8–25.9; Fig. 2). No cases of infected
grafts were reported. Araujo et al. only reported on
infection (which was absent) and therefore their data were
not included in the calculation of wound-related complica-
tions. Various surgical techniques were used, including
onlay, inlay, and underlay (pre- and intraperitoneal)
placement of the biologic graft. Both open and laparoscopic
procedures were performed. Biologic grafts used were
products derived from human acellular dermis (Allo-
derm®), bovine pericardium (Peri-Guard®) and porcine
small intestinal submucosa (Surgisis®). Characteristics of
the biologic grafts used in the included and excluded
studies are given in Table 3.
Studies Excluded From Systematic Review
Six reports on the use of biologic grafts for the repair of
parastomal hernias were excluded after subjecting them to
the modified MINORS tool, including retrospective stud-
ies,20,23 case reports19,21 and case series18,22 (Table 4). Two
case reports and two case series described the use of
biologic grafts for the repair of parastomal hernia. Green-
stein and Aldoroty19 reported on a patient with a history of
ulcerative colitis and four ileostomy revisions that pre-
sented with unremitting obstructive symptoms. An incar-
cerated parastomal hernia confirmed by CT was repaired
using cross-linked porcine dermis (Collamend®) in a
retromuscular fashion. Patient regained ileostomy function
within a few days and when seen at 18 months was pain
free with no evidence of graft infection, hernia recurrence,
ileostomy malfunction or obstruction. Lo Menzo et al.21
reported on a patient with a history of abdominoperineal
resection for rectal cancer that presented with a three-time
n=333
Titles and abstracts screened
after duplicate removal
n=16
Full  text articles assessed
for eligibility
n=10
Full  text articles included and
subjected to MINORS
n=6
Articles excluded
Review article (n=1)12
Unretrievable (n=2)13,14
Concomitant midline hernia repair
(n=2)15,16
Prophylactic use at initial ostomy(n=1)17
n=0
Manual cross  reference
search
n=6
Articles excluded from
systematic review
Less than 5 patients (n=5)18 22
Surgical method not reported (n=1)23
n=4
Studies included in systematic
review
n=317
Records excluded
Wrong material
Wrong topic
Fig. 1 Flowchart of search strategy
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recurrent parastomal hernia, for which an expanded poly-
tetrafluoroethylene mesh was used for the last repair using
the keyhole technique. The Sugarbaker technique28 was
employed using bovine pericardium (Veritas®). Postopera-
tively, a seroma developed which resolved spontaneously;
and at 17-month follow-up, there was no evidence of
recurrence, the patient was pain free and satisfied with
cosmetic results. In a case series of three patients, Kish et
al.22 reported on the primary repair of parastomal hernia
using human acellular dermis (Alloderm) as onlay reinforce-
ment. Two patients were followed for 6 months and 1 year,
respectively, and remained hernia free. One patient presented
8 months later with symptoms of intestinal obstruction
treated conservatively. The patient subsequently returned
3 months later with intestinal obstruction and recurrent
parastomal hernia that necessitated an operation for reloca-
tion of the stoma and repeat hernia repair. Inan et al.18
reported on two patients, one with a history of proctectomy
after severe radiation proctitis presenting with discomfort
and obstructive episodes, the other presenting with symp-
tomatic hernia 18 years after abdominoperineal resection.
Both were repaired laparoscopically using cross-linked
porcine dermis (Permacol®), and at 9 and 3 months
postoperatively there was no evidence of recurrence or
mesh-related complications.
Two retrospective studies on the use of cross-linked
porcine dermis (Permacol) for various types of hernia repair
in complex, infected or potentially contaminated settings,
included six patients undergoing parastomal hernia repair.
Of the total of 133 procedures, Franklin et al.23 repaired
parastomal hernia using intraperitoneal onlay mesh in two
patients, showing no recurrences.20 Follow-up ranged 1–
78 months using clinical examination. Loganathan et al.23
reported on repair of four parastomal hernias, one of which
underwent reversal of the colostomy at the time of the
hernia repair. Of the other three patients, one that had six
Table 2 Study characteristics and recurrence rates of studies included in systematic review
Reference Year No. of
patients
MINORS
index
Material used Type of repair No. of wound
complications (%) b
Recurrence (%) Months
follow-up
(range)
Araujo et al.24 2005 13 10 Peri-Guard Onlay n/a 1 (7.7) 50.2 (n/a)a
Aycock et al.25 2007 11 9 Alloderm Inlay (n=8) and onlay
(n=3)
2 (18.2) 3 (27.3) 8.1 (1–21)
Taner et al.26 2009 13 9 Alloderm Under+onlay sandwich 5 (38.5) 2 (15) 9 (4–16)
Ellis27 2010 20 12 Surgisis Intraperitoneal underlay
(Sugarbaker)
4 (20.0) 2 (10) 18 (6–38)
Weighted pooled%c
(95% CI)
– – – – – 26.2% (14.7–39.5) 15.7% (7.8–25.9) –
a This follow-up is that of a larger group of which these patients were part of
b Complications: wound infection (3),5,26 seroma formation (6),26,27 incisional separation (2)26
c Using a fixed-effects (inverse variance) model
0,0 0,2 0,4 0,6 0,8
Combined 0,157 (0,078−0,259)
Ellis26 0,100 (0,012−0,317)
Taner et al. 25 0,154 (0,019−0,454)
Aycock  et al.24 0,273 (0,060−0,610)
Araujo et al .23 0,077 (0,002−0,360)
Proportion (95% confidence interval)
Fig. 2 Weighted pooled propor-
tion (fixed-effects model;
Cochran’s Q=1.917, p=0.5899)
of recurrences after parastomal
hernia repair using biologic
grafts
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previous attempts at hernia repair experienced a recurrence.
This patient developed an ischaemic end ileostomy which
subsequently developed a localised perforation which
manifested as a fistula formation. Another patient also
developed a fistula. Cross-linked porcine dermis (Permacol)
was placed as inlay or onlay. Median follow-up of the
complete series was 377 days (range 85–1,905 days)
performed by clinical examination.
Discussion
The current systematic review evaluated the use of biologic
grafts for parastomal hernia repair, which results in
acceptable rates of recurrence, with a pooled rate of
15.7% (95% CI 7.8–25.9). Wound-related complications
were reported in 26.2% (95% CI 14.7–39.5). Given the
current evidence, biologic grafts do not provide a superior
alternative to other surgical options.
In their review on parastomal hernia from 2003, Carne et
al.1 shed some light on the outcomes of different techniques
of parastomal hernia repair. In studies using synthetic
meshes (intraperitoneal, preperitoneal and fascial onlay),
the overall recurrence rate was 6/77 (7.8%). Infection is
uncommon and only infrequently requires removal of the
mesh. A search of the literature published since reveals
reherniation occurring in 62/371 (16.7%) patients.29–42 As
found by Carne et al., complications were low, with mesh
infection reported in 15/460 (3%) of the patients. In the
current systematic review of parastomal hernia repair using
biologic grafts, rates of recurrence ranged from 7.7% to
27.3%, with a weighted pooled average of 15.7% (95% CI
7.8–25.9). Graft infection was zero, and other wound-
related complications including wound infection were
26.2% (95% CI 14.7–39.5). Thus, these rates are very
similar to those found for synthetic mesh. Notably, even the
risk of mesh infection appears to be low when a synthetic
graft is implanted. Given the current evidence, it cannot be
Table 3 Characteristics and costs of biologic and synthetic prostheses used for parastomal hernia repair
Material Source Additional cross-linking Preparation Costs per cm2a
Alloderm Human dermis None Refrigeration, rehydration $ 35.31
Permacol Porcine dermis Yes; HMDI None $ 18.97
Surgisis Porcine SIS None Rehydration $ 20.00
Collamend Porcine dermis Yes; EDC Rehydration $ 18.88
Peri-guard Bovine pericardium Yes; gluteraldehyde Rehydration $ 3.91
Veritas Bovine pericardium None None $ 22.02
Polypropylene/e-PTFE/Composite – None $ 3.65
a Based on sheet sizes sufficient for parastomal hernia repair, excluding account discount. Manufacturers and distributors were contacted directly
via telephone
SIS small intestinal submucosa; HMDI hexamethylene diisocyanate; EDC 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride; Alloderm
LifeCell Corp., Branchburg, NJ, USA; Permacol Tissue Science Laboratories, Aldershot, UK; Surgisis Cook Surgical, Bloomington, IN, USA;
Collamend Bard Inc., Warwick, RI, USA; Xenmatrix Brennen Medical Inc., St. Paul, MN, USA; Veritas, Peri-Guard Synovis Surgical
Innovations, St. Paul, MN, USA
Table 4 Study characteristics and recurrence rates of studies excluded from systematic review
Reference Year No. of
patients
Material
used
Type of repair No. of wound
complications (%)b
Recurrence (%) Follow-up
(range)
Kish et al.22 2005 3 Alloderm Onlay n/a 1 (33.3) (6–12)
Inan18 2007 2 Permacol Laparoscopic (method not specified) n/a 0 (0) 6 (3–9)
Greenstein & Aldoroty19 2008 1 Collamend Retromuscular/sublay 0 (0) 0 (0) 18
Franklin et al.20 2008 2 Surgisis Intraperitoneal onlay mesh
(Laparoscopic)
n/a 0 (0) n/a
Lo Menzo et al.21 2008 1 Veritas Intraperitoneal (Laparoscopic
Sugarbaker)
1 (100) 0 (0) 17
Loganathan et al.23 2010 3 Permacol n/a 2 (66) 1 (33) 12 (3–62)a
a This follow-up is that of a larger group of which these patients were part of
b Complications: seroma formation (1),21 ischaemic ileostomy and subsequent fistula (1),23 fistula (1)23
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concluded that biologic prostheses are more preferable than
synthetic mesh to reduce the rates of immediate or long-term
complications. Moreover, biologic grafts are very expensive
compared to synthetic mesh (Table 3), which further refutes
their superiority over synthetic mesh to provide not only
effective but also efficient and cost-effective healthcare.
With limited financial resources, careful consideration must
be taken whilst choosing the types of materials to use.
It is well established that parastomal hernias can occur
after great periods of time. Also, on the long run, risk of
infection may remain higher for non-absorbable synthetic
meshes compared to degradable biologic grafts due to a
prolonged presence of foreign body material. Studies with
longer follow-up are therefore imperative to yield more
reliable rates of recurrence and late complications for both
these treatment modalities. The results of this systematic
review were troubled by typical issues of potential bias,
including the lack of uniformity between studies in definition
and reporting of outcomes and patient characteristics.
Given the scarcity of relevant studies, combined with the
variety of biologic grafts used, it is impossible to make a
direct comparison between the different products or types
of material. The same goes for the surgical technique used
(i.e. the type of prosthetic placement), which is also of
relevance for outcome. With synthetic meshes, average
rates of recurrence after sublay mesh (5.7%)34,39 and
intraperitoneal mesh (11.1%)32,33 are lower than after onlay
mesh (22.8%)29–31 or laparoscopically placed intraperito-
neal mesh (16.6%).35–38,40–42 Onlay placement requires
extensive dissection of subcutaneous tissue which predisposes
for hematoma and seroma formation and may disrupt skin
vascularisation leading to impaired wound healing. Moreover,
due to its anatomical position, intra-abdominal pressure may
lead to lateral detachment of the graft resulting in its higher
recurrence rates. On the other hand, sublay and underlay
techniques theoretically benefit from the intra-abdominal
pressures which may help to keep the graft in place.
Concerning complications, the sublay placement again theo-
retically seems the most advantageous of the techniques,
resulting in the least contact between mesh and bowel.
Besides its use for the repair of parastomal hernia, there has
been much debate as to the effectiveness of the prophylactic
placement of a reinforcing prosthesis at the time of initial
stoma formation. In a recent systematic review of the use of a
mesh to prevent parastomal hernia, Tam et al.6 made a strong
case for the use of prophylactic mesh at the time of initial
stoma formation, showing an overall recurrence rate of
15.4%, compared to 55.2% in patients who received a
conventional stoma. Their meta-analysis performed on three
randomised controlled trials yielded similar results. Compli-
cations were very low and did not differ between the two
groups. To date, only one study can be identified that used a
biologic graft for this purpose.17 Hammond et al. compared
the prophylactic use of cross-linked porcine dermis (Permacol)
to conventional stoma formation. After a median follow-up of
only 6.5 months, the conventional group had a recurrence rate
of 33.3%, while the prophylactic group showed no recurren-
ces. No complications were observed. Given the very low rate
of complications associated with prophylactic synthetic mesh
placement, there is as yet no support for the use of biologic
grafts instead of synthetic ones in this surgical scenario.
As mentioned earlier, when studying rates of hernia
recurrence, next to an appropriate follow-up a properly defined
outcome measure is deemed essential to create uniform and
comparable findings. None of the studies in the current review
provided a proper definition of a recurrence. Most studies used
clinical examination to detect hernias, and one study also used
CT imaging in all patients.26 Here, the two patients that had
radiologic evidence of a recurrence continued to be asymp-
tomatic at 385 and 509 days follow-up, respectively,
requiring no revision of their repair. Another study, which
was excluded from this review due to the prophylactic
placement of a biologic graft, also used CT imaging in all
patients to determine hernia occurrence.16 Similarly, the only
two occurrences were found on CT scan and were small
asymptomatic hernias. If these studies had used only clinical
examination, it is conceivable that these asymptomatic
patients might not have been found to have a recurrence.
Most recently, Gurmu et al. examined the inter-observer
reliability of clinical examination of parastomal hernia in
three hospitals.43 This appeared to be low, with kappa values
ranging between 0.29 and 0.73. The correlation between CT
and patient-reported complaints using a colostomy question-
naire was also low, revealing a kappa of 0.45. Even though
the underestimation of rates of (minor) parastomal hernias
may well be very common, its clinical relevance in
asymptomatic and satisfied patients is only manifest in an
increased risk of complications due to the hernia, such as
incarceration and stenosis of bowel. It is hard to estimate
these risks in patients with asymptomatic or small hernias,
but given the marginal amount of recurrences and long-term
complications in the studies discussed in this review and in
the literature, they do not seem to give cause for concern.
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